Living Large: Embracing a Vibrant Lifestyle Amidst the Hustle and Bustle!
Inspiring Journey of Hope: Jane Eshbaugh’s Battle Against Stage IV Pancreatic Cancer
When life throws unexpected challenges, some people find a way to rise above them. Jane Eshbaugh, a passionate skier and dedicated marketing director, recently celebrated a significant milestone by ringing the “victory bell” at the Roswell Park Comprehensive Cancer Center in Buffalo, New York. After being diagnosed with stage IV pancreatic cancer, Jane’s journey has been marked by resilience, determination, and the unwavering support of her family.
From Diagnosis to Determination
Jane’s adventure on the slopes took a drastic turn when she noticed alarming symptoms—unexpected weight loss, swelling in her groin, and discolored urine. In April 2022, she received the life-altering diagnosis of stage IV pancreatic cancer. "It felt like a cruel joke," Jane recalled, reflecting on the shocking news. However, her connection to Roswell Park—where she had participated in biking events for two decades—helped her transition into treatment with a sense of familiarity and hope.
- Diagnosis: Stage IV pancreatic cancer
- Symptoms: Swelling, weight loss, discolored urine
- Date of Diagnosis: April 1, 2022
Navigating Treatment with Strength
Despite not being eligible for surgery, Jane’s oncologist, Dr. Christos Fountzilas, devised a comprehensive treatment plan. Over six months, she underwent a rigorous regimen of FOLFIRINOX chemotherapy every two weeks. Although the treatment was challenging, Jane’s positivity shone through, enabling her to participate in the Empire State Ride shortly after her sessions.
"I never let fear dictate my journey," Jane shared. "Instead of focusing on the negatives, I chose to embrace each day and the experiences it offered."
The Power of Genetic Testing
One of the pivotal moments in Jane’s treatment was her decision to undergo genetic testing on her tumor through PanCAN. The results revealed specific mutations—ERBB2 (HER2), MSI-H, and TMB-H high—which opened the door to targeted immunotherapy options. This breakthrough allowed Jane to transition to the immunotherapy drug Keytruda after completing her chemotherapy.
- Genetic Testing: Conducted through PanCAN
- Key Findings: Actionable mutations for immunotherapy eligibility
- Immunotherapy Drug: Keytruda
Embracing Life Beyond Cancer
Jane’s experience with Keytruda was remarkable. She reported no side effects and felt revitalized, allowing her to return to her favorite activities, like skiing and enjoying ice cream. The moment her doctor informed her that scans showed no evidence of cancer, Jane felt an overwhelming sense of relief and joy. "I was excited to stop treatment when the time came," she said.
Moving forward, Jane will continue with routine scans every three months, remaining vigilant but optimistic about her health.
Support Systems and Self-Care
Throughout her ordeal, Jane credited her family and friends for their unwavering support. Their encouragement played a vital role in her recovery journey. "The love and positivity surrounding me made all the difference," she explained. Alongside this support, Jane maintained a healthy lifestyle, emphasizing the importance of nutritious food, exercise, and mindfulness.
- Support Network: Family, friends, and community
- Healthy Lifestyle: Balanced diet, exercise, and meditation
Looking Ahead with Optimism
Jane’s story is not just one of survival; it’s a testament to the strength of the human spirit. As she embraces each new day, she remains grateful for her journey and the lessons learned. "Adventure continues to inspire me, and I’m committed to celebrating every moment of life," she concluded.
For anyone facing similar battles, Jane’s journey serves as a beacon of hope, reminding us that resilience, support, and a positive outlook can pave the way to recovery.
